Table 4 Age-specific and overall prevalences and 95% CIs for conditions of interest for Afghans and Syrians with consults at MdM clinics across refugee camps on mainland Greece, 2016–2017; prevalence ratios comparing prevalence of a given condition

Asthma

9

17

6

1

33

25

16

13

0

54

0.73

0.63%

1.22%

1.79%

1.49%

1.03%

1.35%

1.09%

2.89%

-

1.41%

(0.47–1.12)

(0.22–1.05)

(0.64–1.80)

(0.36–3.22)

(0.00–4.47)

(0.68–1.38)

(0.82–1.87)

(0.56–1.63)

(1.34–4.44)

-

(1.03–1.78)

Hepatitis B

0

2

0

1

3

0

1

0

0

1

3.58

-

0.14

-

1.49%

0.09%

-

0.07%

-

-

0.03%

(0.37–34.43)

-

(0.00–0.34)

-

(0.00–4.47)

(0.00–0.20)

-

(0.00–0.20)

-

-

(0.00–0.08)

Herpes

2

7

2

0

11

15

15

3

0

33

0.40

0.14%

0.50%

0.60%

-

0.34%

0.81%

1.02%

0.67

-

0.86%

(0.20–0.79)

(0.00–0.34)

(0.13–0.88)

(0.00–1.43)

-

(0.14–0.54)

(0.40–1.22)

(0.51–1.54)

(0.00–1.42)

-

(0.57–1.15)

Hypertension

2

10

22

14

48

1

13

66

28

108

0.53

0.14%

0.72%

6.57%

20.90%

1.49%

0.05%

0.89%

14.67%

42.42%

2.81%

(0.38–0.74)

(0.00–0.34)

(0.27–1.16)

(3.90–9.23)

(10.90–30.89)

(1.07–1.91)

(0.00–0.16)

(0.41–1.37)

(11.39–17.95)

(30.18–54.67)

(2.29–3.34)

IDDM

2

2

2

1

7

0

1

6

1

8

1.05

0.14%

0.14%

0.60%

1.49%

0.22%

-

0.07%

1.33%

1.51%

0.21%

(0.38–2.88)

(0.00–0.34)

(0.00–0.34)

(0.00–1.43)

(0.00–4.47)

(0.06–0.38)

-

(0.00–0.20)

(0.27–2.40)

(0.00–4.54)

(0.06–0.35)

LRTI

139

75

31

9

254

95

31

20

6

152

2.00

9.78%

5.40%

9.25%

13.43%

7.91%

5.12%

2.12%

4.44%

9.09%

3.96%

(1.64–2.43)

(8.24–11.33)

(4.21–6.58)

(6.13–12.37)

(5.05–21.81)

(6.97–8.84)

(4.11–6.12)

(1.38–2.85)

(2.53–6.36)

(1.97–16.21)

(3.34–4.58)

Musculoskeletal

26

33

16

10

85

56

83

26

5

170

0.60

1.83%

2.37%

4.78%

14.93%

2.65%

3.02%

5.67%

5.78%

7.58%

4.43%

(0.46–0.77)

(1.13–2.53)

(1.57–3.18)

(2.48–7.07)

(6.17–23.68)

(2.09–3.20)

(2.24–3.79)

(4.48–6.85)

(3.61–7.94)

(1.02–14.13)

(3.78–5.08)

NIDDM

1

3

16

10

30

0

4

43

7

54

0.66

0.07%

0.22%

4.78%

14.93%

0.93%

-

0.27%

9.56%

10.61%

1.41%

(0.43–1.03)

(0.00–0.21)

(0.00–0.46)

(2.48–7.07)

(6.17–23.68)

(0.60–1.27)

-

(0.01–0.54)

(6.83–12.28)

(2.98–18.23)

(1.03–1.78)

TB

16

9

4

2

31

1

0

4

0

5

7.41

1.13%

0.65%

1.19%

2.99%

0.96%

0.05

-

0.89%

-

0.12%

(2.88–19.02)

(0.58–1.68)

(0.23–1.07)

(0.02–2.36)

(0.00–7.17)

(0.63–1.30)

(0.00–0.16)

-

(0.02–1.76)

-

(0.02–0.24)

Tonsilitis

317

244

54

8

623

144

78

15

3

240

3.10

22.31%

17.55%

16.12%

11.94%

19.39%

7.75%

5.32%

3.33%

4.55%

6.25%

(2.69–3.57)

(20.14–24.48)

(15.55–19.56)

(12.16–20.08)

(3.97–19.91)

(18.02–20.76)

(6.54–8.97)

(4.17–6.48)

(1.67–5.00)

(0.00–9.71)

(5.49–7.02)

URTI

824

519

106

26

1475

734

339

100

15

1188

1.48

57.99%

37.34%

31.64%

38.81%

45.91%

39.53%

23.14%

22.22%

22.73%

30.95%

(1.40–1.58)

(55.42–60.56)

(34.79–39.88)

(26.64–36.65)

(26.82–50.78)

(44.18–47.63)

(37.30–41.75)

(20.98–25.30)

(18.37–26.08)

(12.35–33.11)

(29.49–32.42)